J.B. Chemicals & Pharmaceuticals Lt (Delisted) share price

BSE: 506943Pharmaceuticals & Biotechnology

Face value ₹1 · Listed Feb 1986

Last traded ₹2,408.90 on 16 Jul 2026

Delisted on 12 Oct 2026.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

Jul 2026
- 13 Jul · Suspension of Trading
  Members of the Exchange are hereby informed that the trading in equity shares of JB Chemicals & Pharmaceuticals Limited shall be suspended w.e.f. July 17, 2026 (i.e., closing hours of trading on July 16, 2026) on account of the Scheme of Amalgamation.
- 8 Jul
  General Updates
- 8 Jul · Business
  Intimation of Effective Date
- 7 Jul · Corporate action
  Record date for the purpose of Merger/HiveOff is 17-Jul-2026.
- 7 Jul · Corporate action
  Record Date in the matter of Scheme of Amalgamation of the J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
- 7 Jul · Business
  Receipt of Certified copy of Order passed by National Company Law Tribunal, Ahmedabad Bench ("NCLT") regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with ....

Q4 results, quarter to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

Revenue: ₹904 Cr−4.8% on a year ago · −15.1% on the quarter before
Operating profit: ₹201 Cr−11.2% on a year ago · −32.0% on the quarter before
Net profit: ₹101 Cr−30.4% on a year ago · −48.8% on the quarter before
Earnings per share: ₹6.35−32.2% on a year ago · −49.7% on the quarter before
Operating margin: 22.2%
Net margin: 11.2%

From revenue to net profit, ₹ crore

Revenue904
Materials and goods−274
Employee costs−199
Other expenses−230
Operating profit201
Depreciation−50
Other income+12
One-off items−27
Finance costs−1.2
Profit before tax135
Tax−33
Net profit101

J.B. Chemicals & Pharmaceuticals Lt results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Mar 2026. Results for the quarter to Jun 2026 were due by 14 Aug 2026, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

Revenue
Net profit

Peak revenue ₹1,094 Cr, quarter to Jun 2025; lowest ₹845 Cr, quarter to Dec 2023

Operating and net margin by quarter, per cent

Operating margin
Net margin

₹ crore	Jun 2021Q1	Sep 2021	Dec 2021Q3	Mar 2022	Jun 2022Q1	Sep 2022	Dec 2022Q3	Mar 2023	Jun 2023Q1	Sep 2023	Dec 2023Q3	Mar 2024	Jun 2024Q1	Sep 2024	Dec 2024Q3	Mar 2025Q4	Jun 2025Q1	Sep 2025Q2	Dec 2025Q3	Mar 2026Q4
Revenue from operations	606	593	601	625	785	809	793	762	896	882	845	862	1,004	1,001	963	949	1,094	1,085	1,065	904
	442	466	473	500	612	625	618	599	664	638	621	664	724	730	709	723	793	775	769	703
Materials and goods bought	217	208	206	213	293	302	299	275	310	298	274	300	340	338	317	322	347	345	329	274
Employee costs	98	105	119	116	134	136	138	136	149	148	152	153	167	171	173	177	194	188	191	199
Other expenses	128	153	147	171	185	188	181	188	205	192	196	211	217	221	219	225	252	242	248	230
Operating profit before depreciation	164	127	128	125	173	185	175	164	232	244	223	198	280	271	255	226	301	310	296	201
Operating margin	27.0%	21.4%	21.3%	20.0%	22.0%	22.8%	22.0%	21.5%	25.9%	27.6%	26.4%	23.0%	27.9%	27.0%	26.4%	23.8%	27.5%	28.5%	27.8%	22.2%
Depreciation and amortisation	18	16	17	22	26	28	28	32	31	32	34	41	41	42	42	46	43	44	45	50
Other income	13	20	5	2	1	1	3	5	6	8	7	17	6	10	8	14	15	15	18	12
Finance costs	1	1	1	2	6	8	8	14	12	10	12	9	6	2	3	1	1	1	2	1
Profit before one-off items and tax	158	129	114	103	142	150	141	122	194	209	184	165	240	237	218	193	272	279	267	162
One-off items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−27
Profit before tax	158	129	114	103	142	150	141	122	194	209	184	165	240	237	218	193	272	279	267	135
	39	32	30	18	37	39	35	35	52	58	50	38	63	62	56	47	69	71	69	33
Current tax	39	27	29	32	26	26	14	24	41	44	36	29	54	54	46	46	66	66	63	38
Deferred tax	−1	4	1	−14	11	13	21	11	11	14	14	9	9	8	9	1	4	5	6	−4
Tax rate	24.6%	24.4%	26.4%	17.7%	25.8%	25.9%	24.9%	28.4%	26.8%	27.8%	27.4%	23.4%	26.3%	26.2%	25.5%	24.5%	25.5%	25.6%	25.8%	24.7%
	119	98	84	85	105	111	106	88	142	151	134	126	177	175	162	146	202	208	198	101
Belonging to the company's shareholders	119	98	84	85	105	111	106	88	142	151	134	126	177	175	162	146	202	208	198	101
Belonging to outside owners of subsidiaries	0	0	0	0	0	0	–	0	0	0	0	0	–	0	0	0	0	–	–	0
Other comprehensive income	3	−7	−7	15	1	−12	2	−5	−9	−3	1	−4	7	3	−15	14	4	5	10	7
Total comprehensive income	122	91	77	100	106	99	108	83	134	147	135	122	184	177	148	159	207	213	208	109
Net margin	19.6%	16.5%	14.0%	13.6%	13.4%	13.7%	13.4%	11.5%	15.9%	17.1%	15.8%	14.6%	17.6%	17.4%	16.9%	15.3%	18.5%	19.2%	18.6%	11.2%
Earnings per share	₹7.69	₹6.33	₹5.43	₹5.49	₹6.80	₹7.19	₹6.86	₹5.67	₹9.20	₹9.72	₹8.62	₹8.22	₹11.39	₹11.24	₹10.46	₹9.36	₹12.99	₹13.29	₹12.63	₹6.35
Diluted earnings per share	₹7.69	₹6.32	₹5.41	₹5.48	₹6.78	₹7.13	₹6.79	₹5.60	₹9.07	₹9.54	₹8.46	₹8.06	₹11.17	₹11.00	₹10.24	₹9.17	₹12.75	₹13.08	₹12.45	₹6.32

Earnings per share in rupees, restated for later splits and bonuses.

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

Revenue
Net profit
Borrowings

Peak revenue ₹4,148 Cr, year to Mar 2026; lowest ₹1,368 Cr, year to Mar 2017

Operating and net margin, per cent

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 1.5% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

Revenue4,148
Materials and goods−1,296
Employee costs−773
Other expenses−971
Operating profit1,107
Depreciation−183
Other income+60
One-off items−27
Finance costs−5.6
Profit before tax952
Tax−243
Net profit709

What the company owns

Plant, investments and other assets₹2,620 Cr
Receivables₹781 Cr
Current investments₹739 Cr
Inventory₹683 Cr
Cash and bank₹146 Cr

What pays for it: net worth and liabilities

Net worth₹4,159 Cr
Other liabilities₹418 Cr
Owed to suppliers₹391 Cr

Profit and loss

Consolidated, ₹ crore, years to March.

₹ crore	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue from operations	1,368	1,414	1,643	1,775	2,043	2,424	3,149	3,484	3,918	4,148
	1,136	1,196	1,338	1,397	1,482	1,881	2,454	2,587	2,886	3,040
Materials and goods bought	528	538	596	631	701	843	1,168	1,182	1,317	1,296
Employee costs	207	251	288	323	341	439	543	601	688	773
Other expenses	401	407	453	443	440	599	742	804	882	971
Operating profit before depreciation	232	218	305	378	560	543	696	897	1,032	1,107
Operating margin	17.0%	15.4%	18.6%	21.3%	27.4%	22.4%	22.1%	25.7%	26.3%	26.7%
Materials, % of revenue	38.6%	38.0%	36.3%	35.5%	34.3%	34.8%	37.1%	33.9%	33.6%	31.3%
Employee costs, % of revenue	15.1%	17.8%	17.5%	18.2%	16.7%	18.1%	17.3%	17.3%	17.6%	18.6%
Other expenses, % of revenue	29.3%	28.8%	27.6%	25.0%	21.5%	24.7%	23.6%	23.1%	22.5%	23.4%
Depreciation and amortisation	47	57	56	66	69	73	114	138	171	183
Operating profit after depreciation	185	161	250	311	492	471	581	759	861	925
Other income	50	37	41	51	112	39	10	37	38	60
Finance costs	5	3	4	3	7	5	36	44	12	6
Profit before one-off items and tax	230	194	287	359	597	505	555	752	887	980
One-off items	0	0	0	−10	0	0	0	0	0	−27
Profit before tax	230	194	287	349	597	505	555	752	887	952
	46	55	93	77	148	119	145	199	228	243
Current tax	–	–	79	85	142	128	89	151	200	232
Deferred tax	–	–	14	−8	6	−9	56	48	27	11
	184	138	194	272	449	386	410	553	660	709
Belonging to the company's shareholders	184	138	194	272	448	385	410	553	660	709
Belonging to outside owners of subsidiaries	–	–	–	0	1	1	0	0	0	0
Other comprehensive income	–	–	−4	−15	0	4	−14	−15	9	27
Total comprehensive income	–	–	190	257	449	390	396	538	668	736
Net margin	13.5%	9.8%	11.8%	15.3%	22.0%	15.9%	13.0%	15.9%	16.8%	17.1%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ crore	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,483	1,438	1,813	2,139	2,480	2,923	3,433	4,159
	1,480	1,435	1,810	2,134	2,480	2,923	3,433	4,159
Share capital	16	15	15	15	15	16	16	16
Reserves	1,464	1,420	1,794	2,119	2,465	2,908	3,418	4,143
Belonging to outside owners of subsidiaries	3	3	4	4	–	–	–	–
	26	32	33	26	548	357	14	0
Repayable after a year	0	0	0	0	383	24	0	0
Repayable within a year	26	32	33	26	165	334	14	0
	243	313	345	384	554	868	632	591
Trade payables	83	124	187	224	239	356	411	391
Other financial liabilities	110	117	76	59	80	93	115	126
Other liabilities	17	27	14	22	24	24	22	–
Provisions	4	7	28	46	43	49	62	65
Tax owed	4	6	8	6	5	12	8	9
	65	63	79	85	519	203	208	218
Other financial liabilities	0	1	5	21	15	10	6	1
Other liabilities	2	6	5	3	3	2	2	4
Provisions	6	7	13	14	15	18	23	29
Deferred tax	57	48	57	48	103	149	177	184
Total assets	1,791	1,814	2,238	2,607	3,554	3,994	4,274	4,969
	741	741	686	1,333	1,999	2,126	2,339	2,023
Plant in use, after depreciation	544	568	544	519	532	572	610	612
Plant being built	15	16	26	14	44	63	47	61
Intangible assets	23	30	32	700	1,312	1,375	1,301	1,216
Goodwill	53	53	57	57	57	57	57	57
Intangible assets being developed	0	–	0	5	11	13	16	13
Investments	96	69	13	13	14	24	28	26
Loans given	4	0	5	1	1	1	0	0
Other financial assets	0	0	0	5	19	10	256	30
Deferred tax	0	–	7	6	7	6	8	7
Other assets	6	4	1	12	3	5	16	–
	1,050	1,073	1,553	1,275	1,555	1,868	1,934	2,946
Inventories	244	275	347	410	430	503	529	683
Trade receivables	309	345	389	556	576	687	815	781
Cash and cash equivalents	35	29	29	57	77	88	115	110
Other bank balances	1	2	2	2	2	7	14	36
Current investments	361	334	665	0	192	365	317	739
Loans given	1	4	2	1	1	1	1	1
Other financial assets	15	7	9	43	22	13	14	560
Tax paid in advance	7	16	17	22	27	15	12	37
Other assets	75	61	93	184	228	190	117	–
Net debt	−372	−333	−663	−32	277	−103	−433	−885

Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ crore	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	315	170	626	801	902	704
	457	305	721	933	1,103	960
	−96	−340	−34	−22	−20	−246
Receivables	−70	−293	−42	−72	−50	−57
Inventories	−70	−63	−21	−72	−26	−154
Payables	46	53	32	138	83	−20
Other working capital	−2	−38	−4	−16	−27	−14
Tax paid	−142	−135	−95	−132	−201	−256
Capital spending	48	63	73	127	98	0
Free cash flow	267	107	553	674	805	704
	−231	2	−962	−404	−296	−586
Plant and property sold	27	8	1	1	1	0
Companies bought	−9	0	0	0	0	0
Interest received	1	1	2	4	5	10
Dividends received	0	0	0	0	0	0
	87	−138	357	−385	−580	−123
Borrowings raised	0	0	610	0	0	0
Borrowings repaid	0	0	−87	−192	−344	−14
Interest paid	6	−2	−32	−44	−10	−3
Lease payments	8	−8	0	0	−13	−25
Dividends paid	73	128	128	157	237	313
Shares bought back	0	0	0	0	0	0
Shares issued	0	0	0	0	0	0
Net change in cash	172	34	20	11	27	−5

Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Consolidated, ₹ per share, years to March.

₹ per share	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	₹10.71	₹8.26	₹11.77	₹17.10	₹28.98	₹24.93	₹26.50	₹35.66	₹42.45	₹45.16
As stated that year	₹21.42	₹16.52	₹23.54	₹34.20	₹57.96	₹49.86	₹53.00	₹35.66	₹42.45	₹45.16
	₹10.71	₹8.26	₹11.77	₹17.10	₹28.98	₹24.91	₹26.17	₹34.85	₹41.56	₹44.45
As stated that year	₹21.42	₹16.52	₹23.54	₹34.20	₹57.96	₹49.82	₹52.34	₹34.85	₹41.56	₹44.45
	₹0.50	₹1.00	₹2.50	₹5.50	₹8.25	₹8.25	₹8.88	₹12.25	₹15.50	₹22.00
As declared that year	₹1.00	₹2.00	₹5.00	₹11.00	₹16.50	₹16.50	₹17.75	₹12.25	₹15.50	₹22.00
	–	–	₹92.24	₹92.87	₹117.09	₹138.07	₹160.23	₹188.36	₹220.51	₹258.98
On that year's share count	–	–	₹184.47	₹185.75	₹234.17	₹276.15	₹320.46	₹188.36	₹220.51	₹258.98
Dividend payout	–	–	20.7%	31.2%	28.5%	33.1%	33.5%	34.4%	36.6%	49.8%
Shareholder yield	–	–	–	–	0.8%	1.0%	0.8%	0.6%	0.9%	0.9%
Market cap at the year end (₹ crore)	–	–	2,908	4,084	9,702	12,173	15,242	25,588	25,249	33,120

Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.

Ratio	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue growth	9.0%	3.3%	16.2%	8.0%	15.1%	18.7%	29.9%	10.6%	12.5%	5.9%
Operating profit growth	13.6%	−6.3%	40.2%	23.6%	48.4%	−3.0%	28.0%	28.9%	15.0%	7.3%
Net profit growth	13.7%	−24.8%	40.2%	40.4%	64.7%	−13.9%	6.2%	34.8%	19.4%	7.6%
Earnings per share growth	12.2%	−22.9%	42.5%	45.3%	69.5%	−14.0%	6.3%	34.6%	19.0%	6.4%
	–	–	13.1%	18.7%	27.6%	19.5%	17.8%	20.5%	20.8%	18.7%
	–	–	–	5.6 pts	8.9 pts	−8.1 pts	−1.8 pts	2.7 pts	0.3 pts	−2.1 pts
From the net margin	–	–	–	3.9 pts	8.0 pts	−7.6 pts	−3.5 pts	3.9 pts	1.3 pts	0.3 pts
From asset turnover	–	–	–	1.2 pts	0.6 pts	−0.2 pts	0.3 pts	−2.1 pts	0.6 pts	−1.1 pts
From borrowing	–	–	–	0.4 pts	0.3 pts	−0.3 pts	1.4 pts	0.9 pts	−1.5 pts	−1.3 pts
Return on capital employed	–	–	16.6%	21.2%	26.6%	21.7%	19.2%	23.1%	25.0%	22.2%
Cash conversion	–	–	–	–	70.2%	44.1%	152.6%	144.9%	136.8%	99.2%
Interest cover	34.5	46.1	59.5	102.7	67.9	91.9	16.1	17.1	73.4	166.1
Debt to equity	–	–	0.02	0.02	0.02	0.01	0.22	0.12	0.00	0.00
Receivable days	–	–	69	71	70	84	67	72	76	69
Inventory days	–	–	149	159	181	178	135	155	147	192
Payable days	–	–	51	72	97	97	75	110	114	110
Cash conversion cycle, days	–	–	167	158	153	164	127	117	109	151
Working capital days	–	–	97	88	97	129	104	91	81	129
Asset turnover	–	–	0.92	0.98	1.01	1.00	1.02	0.92	0.95	0.90
Assets per rupee of net worth	–	–	1.21	1.24	1.25	1.23	1.34	1.40	1.30	1.22
Sales per rupee of plant	–	–	3.02	3.12	3.75	4.67	5.92	6.10	6.42	6.78
Capital spending to depreciation	–	–	–	–	0.70	0.87	0.63	0.92	0.57	0.00
Plant being built, % of plant in use	–	–	2.8%	2.8%	4.7%	2.7%	8.3%	11.1%	7.7%	10.0%

No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year: 15.4%
Cash from operations against operating profit: 63.6%

Measure	10 years	5 years	3 years
Revenue growth, yearly rate	12.7%	15.2%	9.6%
Profit growth, yearly rate	15.9%	9.6%	20.1%
Return on equity, average	–	19.4%	20.0%
Return on capital employed, average	–	22.3%	23.4%
Operating margin, average	22.3%	24.7%	26.3%
Net margin, average	15.1%	15.7%	16.6%
Asset turnover, average	–	0.96	0.92
Cash conversion cycle, days, average	–	134	126
Interest cover, average	67.5	72.9	85.5
Debt to equity, average	–	0.07	0.04

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore	5 years	3 years	Latest year
Cash from operations	3,203	2,407	704
Cash from investing	−2,245	−1,286	−586
Cash from financing	−870	−1,088	−123
Capital spending	360	224	0
Dividends paid	962	707	313
Shares bought back	0	0	0
Shares issued for cash	0	0	0
Borrowings raised	610	0	0
Borrowings repaid	637	549	14

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

Check	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9	–	–	–	–	7	3	4	5	8	5
Altman Z-scorePublished threshold 1.81	–	–	8.80	9.50	17.28	18.70	11.27	17.20	21.14	27.78
Beneish M-scorePublished threshold −1.78	–	–	–	–	−2.04	0.01	−2.87	−2.66	−2.42	−2.59
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets	–	–	–	–	17.99	8.82	24.22	4.13	1.28	12.80
Cash from operations to profit, 3 yearsPublished threshold 0.7 times	–	–	–	–	–	–	0.89	1.18	1.44	1.25
Receivables growth less revenue growthOur threshold 0 percentage points	–	–	–	3.68	−2.47	24.15	−26.29	8.66	6.25	−10.09
Inventory growth less cost-of-goods growthOur threshold 0 percentage points	–	–	–	6.92	15.29	−2.17	−33.58	15.54	−6.12	30.74
Other current assets growth less revenue growthOur threshold 5 per cent of revenue	–	–	–	−0.79	1.70	5.40	0.85	−1.67	−1.91	10.93
Assets under construction, years of additionsOur threshold 2 years of additions	–	–	–	0.18	0.57	0.29	0.35	0.36	0.22	0.33
Effective tax ratePublished threshold 17.16 per cent	19.81	28.48	32.41	21.93	24.86	23.54	26.16	26.46	25.67	25.50
Tax charged less tax paid, % of profitOur threshold 10 percentage points	–	–	–	–	–	−3.12	8.96	8.84	3.06	−1.41

A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

Date	Agency	Borrowing rated	Rating	Outlook	Amount, ₹ Cr
17 Mar 2026	CRISIL Ratings Limited	Bank FacilitiesShort-term scale	Crisil A1+Rating Reaffirmed		50
17 Mar 2026	CRISIL Ratings Limited	Bank FacilitiesShort-term scale	Crisil A1+Rating Reaffirmed		3
17 Mar 2026	CRISIL Ratings Limited	Bank FacilitiesLong-term scale	Crisil AA+Rating Upgraded	Stable	171
17 Mar 2026	CRISIL Ratings Limited	Bank FacilitiesShort-term scale	Crisil A1+Rating Reaffirmed		90
17 Mar 2026	CRISIL Ratings Limited	Bank FacilitiesLong-term scale	Crisil AA+Rating Upgraded	Stable	65

The latest rating on each borrowing. The agency's name opens its reasoning for the rating.

Business segments

In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	+28.2%	+4.3%	+22.0%	1.1%
3 years	+28.9%	+18.6%	+7.9%	0.9%
5 years	+27.8%	+8.8%	+16.6%	0.9%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Who owns J.B. Chemicals & Pharmaceuticals Lt, filing by filing

Per cent of the company's shares. Every filing on record, from Sep 2021; the latest is the filing for Mar 2026.

Mar 2026 filing

Promoters48.80%
Foreign institutions16.33%
Indian institutions21.38%
GovernmentsNone
Individuals and others13.48%

Shareholding pattern, per cent, from Sep 2022

Promoters
Foreign institutions
Indian institutions
Governments
Individuals and others

Per cent	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	55.91%	54.00%	54.00%	54.00%	53.96%	53.93%	53.91%	53.86%	53.83%	53.78%	53.77%	53.74%	53.66%	47.84%	47.73%	47.56%	47.55%	48.80%
Indian promoters	1.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	–	–	48.80%
Foreign promoters	54.00%	54.00%	54.00%	54.00%	53.96%	53.93%	53.91%	53.86%	53.83%	53.78%	53.77%	53.74%	53.66%	47.84%	47.73%	47.56%	47.55%	0.00%
	44.09%	46.00%	46.00%	46.00%	46.04%	46.07%	46.09%	46.14%	46.17%	46.22%	46.23%	46.26%	46.34%	52.16%	52.27%	52.44%	52.45%	51.20%
	–	–	–	–	8.66%	8.63%	9.54%	10.05%	10.35%	11.06%	12.17%	13.63%	14.64%	18.30%	17.77%	15.30%	14.88%	16.33%
Foreign portfolio investors, category I	–	–	–	–	8.08%	8.17%	9.14%	9.72%	10.07%	10.77%	11.74%	13.27%	14.30%	16.68%	16.29%	13.87%	13.66%	15.16%
Foreign portfolio investors, category II	–	–	–	–	0.58%	0.45%	0.39%	0.33%	0.28%	0.29%	0.43%	0.34%	0.32%	1.61%	1.48%	1.44%	1.22%	1.17%
	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.02%	0.02%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Foreign Banks	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	–	Under 0.01%	–
Foreign Bank	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	–	Under 0.01%
	–	–	–	–	18.48%	19.08%	18.65%	18.58%	18.54%	18.38%	17.62%	16.81%	16.41%	18.72%	19.63%	22.83%	23.36%	21.38%
Mutual funds	12.80%	13.75%	14.27%	15.12%	15.40%	16.17%	15.57%	15.57%	15.66%	15.45%	15.04%	14.60%	14.57%	16.26%	16.27%	19.15%	19.61%	19.00%
Insurance companies	1.96%	2.28%	2.39%	2.40%	2.67%	2.39%	2.55%	2.45%	2.30%	2.36%	1.93%	1.62%	1.25%	1.77%	2.68%	2.21%	2.16%	1.33%
Banks	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Alternative investment funds	0.48%	0.22%	0.23%	0.28%	0.40%	0.52%	0.53%	0.56%	0.57%	0.57%	0.64%	0.58%	0.58%	0.68%	0.67%	1.47%	1.58%	1.05%
Non-bank lenders registered with RBI	–	–	–	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
	–	–	–	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	Under 0.01%	0.01%	Under 0.01%	0.00%	–	0.00%	Under 0.01%	Under 0.01%
Central government	–	–	–	–	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	Under 0.01%	0.01%	Under 0.01%	0.00%	–	0.00%	Under 0.01%	Under 0.01%
Government-promoted companies	–	–	–	–	0.00%	Under 0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	–	–	–
	–	–	–	–	18.91%	18.36%	17.91%	17.51%	17.28%	16.78%	16.43%	15.81%	15.29%	15.14%	14.88%	14.30%	14.22%	13.48%
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	14.85%	13.75%	13.44%	13.15%	13.15%	13.14%	12.95%	12.72%	12.34%	12.20%	12.11%	11.65%	11.40%	11.04%
Resident individuals, over ₹2 lakh at face value	–	–	–	–	2.09%	2.22%	2.22%	2.18%	2.01%	1.55%	1.43%	1.15%	1.08%	1.08%	0.94%	0.82%	0.96%	0.73%
Companies	–	–	–	–	0.68%	0.66%	0.59%	0.57%	0.54%	0.54%	0.54%	0.53%	0.51%	0.50%	0.42%	0.68%	0.66%	0.56%
Non-resident Indians	–	–	–	–	0.97%	0.96%	0.87%	0.83%	0.83%	0.82%	0.78%	0.69%	0.64%	0.64%	0.65%	0.51%	0.54%	0.50%
Foreign nationals	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.02%
Investor education fund	–	–	–	–	0.31%	0.35%	0.36%	0.36%	0.36%	0.36%	0.36%	0.36%	0.38%	0.37%	0.37%	0.37%	0.37%	0.35%
Directors and their relatives	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	0.03%	0.00%	–	–
Key managers	–	–	–	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	0.01%	Under 0.01%	Under 0.01%	–
	–	–	–	–	0.01%	0.41%	0.42%	0.41%	0.38%	0.37%	0.36%	0.35%	0.34%	0.34%	0.34%	0.28%	0.28%	0.28%
Trusts	–	–	–	–	Under 0.01%	Under 0.01%	0.02%	0.01%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%
Clearing Members	–	–	–	–	0.01%	Under 0.01%	0.01%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Hindu undivided families	–	–	–	–	–	0.41%	0.40%	0.39%	0.38%	0.36%	0.36%	0.35%	0.34%	0.34%	0.33%	0.28%	0.27%	0.27%
Shares in issue	7,72,82,097	7,72,82,097	7,72,82,097	7,72,82,097	7,73,35,457	7,73,77,584	7,74,16,884	15,49,55,510	15,50,44,160	15,51,94,800	15,52,13,058	15,53,14,408	15,55,48,728	15,56,77,208	15,60,58,924	15,65,96,239	15,66,50,956	16,05,58,706
Shares locked in	0	0	0	0	0	1,482	2,782	7,420	13,914	31,834	36,286	38,086	17,949	21,549	26,363	26,363	14,095	–

Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of J.B. Chemicals & Pharmaceuticals Lt shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

Shareholders	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
All shareholders	71,788	64,861	61,314	60,268	58,629	56,633	55,965	60,817	63,230	63,892	66,953	62,743	62,081	63,948	70,064	71,957	69,338	74,043
	6	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Indian promoters	5	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–	1
Foreign promoters	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	–
	71,782	64,860	61,313	60,267	58,628	56,632	55,964	60,816	63,229	63,891	66,952	62,742	62,080	63,947	70,063	71,956	69,337	74,042
	–	–	–	–	150	157	161	165	173	194	203	221	238	257	254	222	214	214
Foreign portfolio investors, category I	–	–	–	–	134	142	143	147	155	175	186	201	216	233	230	198	191	190
Foreign portfolio investors, category II	–	–	–	–	15	14	17	17	17	18	16	18	20	22	23	23	22	23
	–	–	–	–	1	1	1	1	1	1	1	2	2	2	1	1	1	1
Foreign Banks	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	–	1	–
Foreign Bank	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	–	1
	–	–	–	–	56	53	52	54	57	60	61	57	55	62	57	61	63	69
Mutual funds	30	29	32	30	29	31	31	31	34	34	31	30	29	31	31	33	33	36
Insurance companies	7	9	9	10	11	11	11	11	10	12	12	12	12	13	12	10	9	11
Banks	–	–	–	–	4	4	4	4	4	4	4	4	4	3	3	3	3	3
Alternative investment funds	11	9	7	9	12	5	4	7	7	8	12	9	9	14	10	14	16	18
Non-bank lenders registered with RBI	–	–	–	–	0	2	2	1	2	2	2	2	1	1	1	1	2	1
	–	–	–	–	0	1	1	1	1	1	1	1	1	0	–	0	1	1
Central government	–	–	–	–	0	0	1	1	1	1	1	1	1	0	–	0	1	1
Government-promoted companies	–	–	–	–	0	1	0	0	0	0	0	0	0	0	–	–	–	–
	–	–	–	–	58,422	56,421	55,750	60,596	62,998	63,636	66,687	62,463	61,786	63,628	69,752	71,673	69,059	73,758
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	56,484	53,535	52,862	57,434	59,724	60,286	63,486	59,394	58,750	60,461	66,368	68,335	65,784	70,053
Resident individuals, over ₹2 lakh at face value	–	–	–	–	4	5	5	5	5	4	4	3	3	3	2	2	3	2
Companies	–	–	–	–	419	396	404	458	469	463	450	405	382	389	419	393	364	389
Non-resident Indians	–	–	–	–	1,468	1,482	1,491	1,673	1,752	1,853	1,711	1,688	1,667	1,741	1,910	1,922	1,911	2,197
Foreign nationals	–	–	–	–	0	0	0	0	0	0	1	1	1	1	1	1	1	2
Investor education fund	–	–	–	–	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Directors and their relatives	–	–	–	–	0	0	0	0	0	0	0	0	0	1	1	0	–	–
Key managers	–	–	–	–	0	2	1	1	0	0	0	0	1	1	1	1	1	–
	–	–	–	–	46	1,000	986	1,024	1,047	1,029	1,034	971	981	1,030	1,049	1,018	994	1,114
Trusts	–	–	–	–	1	1	5	6	5	7	4	3	5	4	5	5	3	5
Clearing Members	–	–	–	–	45	8	7	3	3	4	5	5	3	1	5	4	2	4
Hindu undivided families	–	–	–	–	–	991	974	1,015	1,039	1,018	1,025	963	973	1,025	1,039	1,009	989	1,105

J.B. Chemicals & Pharmaceuticals Lt promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Mar 2026; the largest is TORRENT PHARMACEUTICALS LIMITED, 48.80%. The filing names 20 more members with no shares.

Holder
TORRENT PHARMACEUTICALS LIMITEDIndian companies, trusts and others	48.80%	7,83,57,892

No promoter shares are reported as pledged.

Largest public holders of J.B. Chemicals & Pharmaceuticals Lt, filing by filing

Per cent, on the same shares as the split above.

Holder	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
GOVERNMENT PENSION FUND GLOBALForeign portfolio investors, category I	1.04%	1.24%	1.49%	1.55%	1.55%	1.60%	1.60%	1.60%	1.59%	1.59%	1.59%	1.59%	1.62%	1.70%	1.80%	1.89%	1.89%	1.84%
SMALLCAP WORLD FUND, INCForeign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	1.05%	1.05%	–	–	1.30%
TATA AIA LIFE INSURANCE COMPANY LTD - NON UNIT LINKED LIFE POLICY HOLDERS FUND PARTICIPATINGInsurance companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.30%	1.29%	1.28%	–
ABERDEEN STANDARD SICAV I - INDIAN EQUITY FUNDForeign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	1.04%	1.10%	–	–	–	–
KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD.Insurance companies	1.05%	1.26%	1.35%	1.36%	1.33%	1.20%	1.14%	1.03%	1.01%	1.00%	–	–	–	–	–	–	–	–

A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

Who moved in the Mar 2026 filing

Against the Jan 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.

Foreign institutions: SMALLCAP WORLD FUND, INC newly named at 1.30%

J.B. Chemicals & Pharmaceuticals Lt dividend calendar

Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2026.

Paid 19 years running, from the year to Mar 2008
Raised 4 years running

Dividends by the month each went ex
Year	Feb	Mar	May	Jul	Aug	Sep	In the year
2026	₹12.70		₹9.30				₹22.00
2025	₹8.50			₹7.00			₹15.50
2024	₹5.50				₹6.75		₹12.25
2023	₹8.50				₹9.25		Not added up
2022	₹8.50				₹8.00		₹16.50
2021	₹8.50					₹8.00	₹16.50
2020		₹10.00				₹1.00	₹11.00
2019					₹5.00		₹5.00

Interim or final dividendSpecial dividendNone that month

Dividends by year

The share of each year's profit paid out, for the year it was paid for.

Share of profit paid out, %, where the year's results are on record

Highest 50% of profit, year to Mar 2026.

J.B. Chemicals & Pharmaceuticals Lt dividend history

Every payment with its ex-date and record date, year by year.

2026₹22.00 a share in 2 payments

May29Fri
₹9.30Final
Ex-date and record date 29 May 2026 · announced 11 May 2026
0.42%of the price
Feb11Wed
₹12.70Interim
Ex-date and record date 11 Feb 2026 · announced 5 Feb 2026
0.66%of the price

2025₹15.50 a share in 2 payments

Jul30Wed
₹7.00Final
Ex-date and record date 30 Jul 2025 · announced 14 May 2025
0.39%of the price
Feb7Fri
₹8.50Interim
Ex-date 7 Feb 2025 · record date 8 Feb 2025 · announced 4 Feb 2025
0.50%of the price

2024₹12.25 a share in 2 payments

Aug14Wed
₹6.75Final
Ex-date and record date 14 Aug 2024 · announced 17 May 2024
0.35%of the price
Feb16Fri
₹5.50Interim
Ex-date and record date 16 Feb 2024 · announced 6 Feb 2024
0.33%of the price

2023

Aug17Thu
₹9.25Final
Ex-date and record date 17 Aug 2023 · announced 24 May 2023
0.35%of the price
Feb17Fri
₹8.50Interim
Ex-date 17 Feb 2023 · record date 18 Feb 2023 · announced 8 Feb 2023
0.43%of the price

2022₹16.50 a share in 2 payments

Aug12Fri
₹8.00Final
Ex-date 12 Aug 2022 · books closed to 24 Aug 2022
0.44%of the price
Feb23Wed
₹8.50Interim
Ex-date 23 Feb 2022 · record date 24 Feb 2022 · announced 14 Feb 2022
0.52%of the price

2021₹16.50 a share in 2 payments

Sep1Wed
₹8.00Final
Ex-date 1 Sep 2021 · books closed to 9 Sep 2021 · announced 14 Jun 2021
0.47%of the price
Feb18Thu
₹8.50Interim
Ex-date 18 Feb 2021 · record date 22 Feb 2021 · announced 10 Feb 2021
0.73%of the price

2020₹11.00 a share in 2 payments

Sep22Tue
₹1.00Final
Ex-date 22 Sep 2020 · books closed to 30 Sep 2020
0.09%of the price
Mar3Tue
₹10.00Interim
Ex-date 3 Mar 2020 · record date 4 Mar 2020 · announced 20 Feb 2020
1.88%of the price

2019

Aug14Wed
₹5.00Final
Ex-date 14 Aug 2019 · record date 16 Aug 2019 · announced 21 May 2019
1.34%of the price

2018

Aug27Mon
₹2.00Final
Ex-date 27 Aug 2018 · books closed to 4 Sep 2018 · announced 25 May 2018
0.61%of the price

2017

Sep11Mon
₹1.00Final
Ex-date 11 Sep 2017 · books closed to 19 Sep 2017
0.36%of the price

2016₹5.00 a share in 2 payments

Aug11Thu
₹0.50Final
Ex-date 11 Aug 2016 · books closed to 23 Aug 2016
0.18%of the price
Mar17Thu
₹4.50Interim
Ex-date 17 Mar 2016 · record date 19 Mar 2016
1.74%of the price

2015₹14.00 a share in 2 payments

Aug6Thu
₹4.00Final
Ex-date 6 Aug 2015 · books closed to 19 Aug 2015
1.39%of the price
Aug6Thu
₹10.00Special
Ex-date 6 Aug 2015 · books closed to 19 Aug 2015
3.46%of the price

2014

Sep4Thu
₹3.00Final
Ex-date 4 Sep 2014 · books closed to 15 Sep 2014
1.30%of the price

2013

Aug1Thu
₹3.00Final
Ex-date 1 Aug 2013 · books closed to 14 Aug 2013
3.76%of the price

2012

Jul19Thu
₹1.00Final
Ex-date 19 Jul 2012 · books closed to 30 Jul 2012
1.42%of the price

2011₹42.00 a share in 2 payments

Aug29Mon
₹40.00Interim
Ex-date 29 Aug 2011 · record date 31 Aug 2011
28.36%of the price
Jul14Thu
₹2.00Final
Ex-date 14 Jul 2011 · books closed to 25 Jul 2011
1.42%of the price

2010

Jul15Thu
₹2.00Final
Ex-date 15 Jul 2010 · books closed to 23 Jul 2010
2.05%of the price

2009

Jul2Thu
₹1.00Final
Ex-date 2 Jul 2009 · books closed to 13 Jul 2009
2.23%of the price

2008

Jul3Thu
₹0.50Final
Ex-date 3 Jul 2008 · books closed to 18 Jul 2008
1.26%of the price

2007

Jul12Thu
₹1.50Final
Ex-date 12 Jul 2007 · books closed to 27 Jul 2007
2.09%of the price

Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date. A book closure is the run of days the company's register is frozen to settle who is paid; a record date is the one-day form of it.

J.B. Chemicals & Pharmaceuticals Lt share price by year

Each calendar year to 2025.

Year	Close at year end	Change	Highest close	Lowest close
2025	1,819.70	−1.3%	1,896.40	1,504.40
2024	1,844.15	+13.5%	1,970.60	1,531.40
2023BSE close	1,624.65	+67.2%	1,624.65	956.68
2022BSE close	971.68	+9.2%	1,059.65	718.05
2021	889.85	+75.0%	978.60	493.58
2020	508.55	+139.0%	562.93	214.75
2019	212.83	+39.1%	215.50	149.68
2018BSE close	152.95	−8.4%	171.98	124.05
2017BSE close	166.95	−4.7%	179.08	129.80
2016BSE close	175.28	+25.6%	197.15	118.15

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.

Recent sessions

The 10 trading days to 16 Jul 2026, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
16 Jul 2026	2,506.00	2,525.50	2,380.00	2,408.90	2,418.56	47,79,224
15 Jul 2026	2,491.00	2,510.00	2,441.30	2,506.00	2,490.90	7,17,650
14 Jul 2026	2,460.00	2,491.00	2,449.10	2,487.60	2,480.65	8,37,560
13 Jul 2026	2,415.20	2,470.00	2,406.60	2,460.00	2,450.23	4,55,413
10 Jul 2026	2,440.00	2,444.80	2,386.80	2,435.50	2,425.07	4,11,937
9 Jul 2026	2,436.20	2,474.00	2,430.10	2,444.50	2,453.80	2,15,631
8 Jul 2026	2,426.50	2,467.70	2,412.10	2,435.80	2,442.46	11,69,387
7 Jul 2026	2,394.80	2,428.80	2,390.00	2,422.00	2,419.63	8,23,042
6 Jul 2026	2,360.00	2,393.00	2,350.40	2,390.00	2,370.39	1,69,754
3 Jul 2026	2,328.00	2,371.80	2,327.90	2,364.60	2,357.26	1,08,305

Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-date	Event	Price factor	What happened
18 Sep 2023	Split	0.5000	Each share became 2.
29 Aug 2011	Price move	–	A corporate action went ex within three days of this move (Interim Dividend - Rs. - 40.0000, ex-date 29 Aug 2011), and its terms do not account for the move. Not adjusted for.

Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Any other event is noted and not adjusted for.

Company details

BSE code: 506943
ISIN: INE572A01036
Industry: Pharmaceuticals & Biotechnology
Former symbols: JBCHEPHARM
Website: www.jbpharma.com
CIN: L24390MH1976PLC019380; Corporate identity number, the registrar of companies' code for it
Incorporated: 1976
Registered office: 302, Iscon Mall, Star India Bazar Building, Opp. Jodhpur BRTS Satellite, Ahmedabad 380015, Gujarat
Share registrar: Datamatics Business Solutions Ltd; Keeps the register of shareholders and handles transfers and dividend payments